Skip to content

SERCOLAB: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

SERCOLAB

BE 0431.052.360
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€35,177
2024 · €49,628-€84,805
Equity
€77,663
2024 · €112,840-€35,177
Cash
€44,650
2024 · €4,286+€40,364
Balance sheet total
€389,069
2024 · €483,986-€94,917

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€104,569

    down €104,569 (-33.7%), from €310,131 to €205,562

    of which Trade receivables: -€104,686

  • Cash +€40,364

    up €40,364 (+941.8%), from €4,286 to €44,650

    mainly Receivables within one year (+€104,569) and Stocks and contracts (+€32,223)

  • Stocks and contracts -€32,223

    down €32,223 (-19.8%), from €162,760 to €130,537

Equity and liabilities
  • Trade debts -€44,788

    down €44,788 (-22.4%), from €200,251 to €155,463

  • Profit (loss) carried forward -€35,177

    down €35,177 (-43.0%), from €81,896 to €46,719

  • Tax, wage and social debts -€31,010

    down €31,010 (-51.1%), from €60,639 to €29,629

    of which Taxes: -€31,147

  • Other debts +€16,500

    up €16,500 (+15.9%), from €103,500 to €120,000

Income statement
  • Gross operating margin -€72,821

    down €72,821 (-38.6%), from €188,549 to €115,727

  • Financial income -€23,735

    down €23,735 (-98.8%), from €24,030 to €294

    of which Non-recurring financial income: -€24,010

  • Taxes -€11,614

    down €11,614 (-98.0%), from €11,854 to €240

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €49,628
Gross operating margin -€72,821
Staff costs +€1,046
Depreciation -€376
Other operating charges -€365
Financial income -€23,735
Financial charges -€168
Taxes +€11,614
Result 2025 -€35,177

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€43,799
Investment -€2,993
Financing -€442
Cash 2024 €4,286
Net result for the year -€35,177
Depreciation +€1,482
Stocks and contracts +€32,223
Receivables within one year +€104,569
Trade debts -€44,788
Tax, wage and social debts -€31,010
Other debts +€16,500
Investment in fixed assets (net) -€2,993
Current portion of long-term debt -€442
Cash 2025 €44,650
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €483,986 €389,069 -€94,917 -19.6%
Fixed assets 21/28 €6,809 €8,320 +€1,511 +22.2%
Tangible fixed assets 22/27 €2,396 €3,907 +€1,511 +63.1%
Plant, machinery and equipment 23 €2,396 €3,907 +€1,511 +63.1%
Financial fixed assets 28 €4,413 €4,413 = 0.0%
Current assets 29/58 €477,177 €380,749 -€96,428 -20.2%
Stocks and contracts in progress 3 €162,760 €130,537 -€32,223 -19.8%
Stocks 30/36 €162,760 €130,537 -€32,223 -19.8%
Amounts receivable within one year 40/41 €310,131 €205,562 -€104,569 -33.7%
Trade receivables 40 €309,586 €204,900 -€104,686 -33.8%
Other amounts receivable 41 €545 €661 +€117 +21.4%
Cash at bank and in hand 54/58 €4,286 €44,650 +€40,364 +941.8%
Deferred charges and accrued income 490/1 €0 €0 =
Total equity and liabilities 10/49 €483,986 €389,069 -€94,917 -19.6%
Equity 10/15 €112,840 €77,663 -€35,177 -31.2%
Contributions 10/11 €18,550 €18,550 = 0.0%
Reserves 13 €12,395 €12,395 = 0.0%
Non-distributable reserves 130/1 €1,855 €1,855 = 0.0%
Reserves not available under the articles 1311 €1,855 €1,855 = 0.0%
Distributable reserves 133 €10,540 €10,540 = 0.0%
Profit (loss) carried forward 14 €81,896 €46,719 -€35,177 -43.0%
Amounts payable 17/49 €371,145 €311,405 -€59,740 -16.1%
Amounts payable within one year 42/48 €371,145 €311,405 -€59,740 -16.1%
Current portion of amounts payable after more than one year 42 €6,756 €6,314 -€442 -6.5%
Trade debts 44 €200,251 €155,463 -€44,788 -22.4%
Suppliers 440/4 €200,251 €155,463 -€44,788 -22.4%
Taxes, remuneration and social security 45 €60,639 €29,629 -€31,010 -51.1%
Taxes 450/3 €45,209 €14,062 -€31,147 -68.9%
Remuneration and social security 454/9 €15,430 €15,567 +€137 +0.9%
Other amounts payable 47/48 €103,500 €120,000 +€16,500 +15.9%
Remuneration, social security and pensions 62 €148,111 €147,065 -€1,046 -0.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,106 €1,482 +€376 +34.0%
Other operating charges 640/8 €505 €870 +€365 +72.2%
Gross operating margin 9900 €188,549 €115,727 -€72,821 -38.6%
Operating profit (loss) 9901 €38,827 -€33,690 -€72,516
Financial income 75/76B €24,030 €294 -€23,735 -98.8%
Recurring financial income 75 €20 €294 +€274 +1367.9%
Non-recurring financial income 76B €24,010 - -€24,010
Financial charges 65/66B €1,374 €1,542 +€168 +12.2%
Recurring financial charges 65 €1,374 €1,542 +€168 +12.2%
Profit (loss) for the period before taxes 9903 €61,482 -€34,937 -€96,420
Income taxes 67/77 €11,854 €240 -€11,614 -98.0%
Profit (loss) for the period 9904 €49,628 -€35,177 -€84,805
Profit (loss) for the period to be appropriated 9905 €49,628 -€35,177 -€84,805

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.